Endoscopy Simulator Market - Forecasts from 2023 to 2028

Endoscopy Simulator Market - Forecasts from 2023 to 2028

The global endoscopy simulator market is projected to witness a compound annual growth rate (CAGR) of 14.16% over the period of 2020 and 2027. An endoscopy simulator, also known as an endoscopic simulator, is a training and instructing tool for learners and healthcare professionals. Endoscopy simulators are used to provide the best diagnostic-therapeutic results while reducing patient risks. It has been regarded as a newer approach to ensuring patient safety, with the increasing need for sophisticated, invasive procedures that decrease upper gastrointestinal endoscopy, colonoscopy, and flexible sigmoidoscopy training possibilities. In order to achieve this degree of safety, endoscopic errors must be reduced, and training results must be enhanced and accelerated. Additionally, the market for endoscopy simulators has benefited from the popularity of minimally invasive surgeries in the healthcare industry. According to a study in the National Library of Medicine (NIH), published in February 2020, the number of open surgical operations fell by over 35% between 2000 and 2018 and were being replaced with minimally invasive techniques. With the rising prevalence of diseases and the increasing number of minimally invasive surgeries, the need for efficient training is essential. Due to this, the demand for advanced and realistic simulators has grown.

Based on geography, the global endoscopy simulator market is divided into North America, South America, Europe, Asia Pacific, the Middle East, and Africa. During the forecast period, the North American and Asia Pacific region is expected to hold considerable market shares in 2027 due to rising R&D investments in advanced technologies in the regions. The US is expected to witness healthy growth owing to the rising partnerships and product launches by major firms in the country. For instance, the need for an ERCP simulator that provides accurate interactions and feedback, enabling the learner to experience the contact between the scope and the patient's tissue, led to the development of the Immersion Medical ERCP module by Immersion Medical.

Growing disease and cancer cases have led to product innovations and development which are driving market growth. The increasing number of diseases and cancer cases has led to expanded demand for endoscopy tests and diagnosis. The American Cancer Society estimates that a total of 1.9 million new cancer cases would be diagnosed in the year 2022, leading to about 609,360 cancer deaths. According to statistics released by Cancer.net in January 2022, stomach cancer accounts for around 1.5% of cancer cases diagnosed each year in the United States. In 2020, an estimated 1,089,103 people have been diagnosed with the condition worldwide, and an estimated 768,793 deaths occurred in the year. This has resulted in increasing advancements in the endoscopy simulator market. For instance, In June 2021, InSimo, a company specializing in the creation of simulation software for training in medicine and surgery. The company announced the beginning of the ENSIST project (Endoscopic Simulation for Surgical Training). This project will be developing simulation modules to teach endoscopic surgery new surgical procedures. In addition, in January 2022, CeMSIM (RPI) along with Beth Israel Deaconess Medical Center in Boston and Kitware collaborated to develop a virtual endoscopic surgical simulator (VESS).

Market Segmentation:

By Procedure

Upper and Lower Flexible Endoscopy
Bronchoscopy
Urology

By End-User

Hospitals
Academic Institutes

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
UK
Italy
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Taiwan
Thailand
Indonesia
Others